Drug Trial Radar · NCT07935343
Comparison of Topical Permethrin 5% and Spinosad 0.9% for Scabies Treatment
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
180
Planned (sponsor's estimate)
Start
Feb 2027
Primary completion
Jul 2027
Study completion Jul 2027
Sponsor
- Lead sponsor
- University of FaisalabadAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 13, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 5 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this randomized controlled clinical trial is to compare the effectiveness of topical Permethrin 5% cream and Spinosad 0.9% suspension in treating scabies in patients aged 5-60 years. The main questions it aims to answer are: * Is there a difference in the effectiveness of topical Permethrin 5% and Spinosad 0.9% in treating scabies at Day 14? * What are the treatment-related adverse effects of these two medications? Researchers will compare the two treatment groups to determine whether there is a significant difference in treatment efficacy. Participants will be randomly assigned to one of two groups: * Group A will receive topical Permethrin 5% cream, applied from the neck to the toes for 8-12 hours, followed by washing. A second application will be given after 7 days. * Group B will receive topical Spinosad 0.9% suspension, applied similarly, with repeat application only if clinically indicated. Participants will be instructed regarding correct treatment application, hygiene measures, and treatment of close contacts. They will be assessed at baseline, Day 7, and Day 14. The main outcome will be treatment efficacy at Day 14, defined as complete resolution of itching, healing of skin lesions, and absence of new lesions.
Conditions
- Scabies
Interventions
Permethrin 5%Drug
Patients will receive topical Permethrin 5% cream applied from neck to toe for 8-12 hours followed by washing. A second application will be given after 7 days.
spinosad topical suspension, 0.9%Drug
Patients will receive topical Spinosad 0.9% suspension. Repeat application will be performed only if clinically indicated.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants achieving treatment efficacy at day 14Time frame: Day 14 after treatment initiation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Madina Teaching Hospital
Faisalābad, Punjab Province, Pakistan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.